TL;DR:
- Hippocratic AI launches an Early Access Partnership Program with healthcare leaders.
- Participants include OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth.
- The program focuses on developing safe, non-diagnostic AI solutions for healthcare.
- Early Access Partners will shape product-market fit, provide clinical insights, and pilot use cases.
- This initiative aims to enhance patient care, address staffing shortages, and revolutionize healthcare delivery.
Main AI News:
In a bold move that underscores its commitment to revolutionizing healthcare, Hippocratic AI has unveiled its Early Access Partnership Program. This strategic initiative brings together prominent figures in the healthcare sector to propel the development of Hippocratic AI’s cutting-edge technology while validating priority use cases. Among the distinguished participants in this program are renowned health systems and digital health enterprises such as OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth, among others.
Michael Krouse, Chief Strategy and Transformation Officer at OhioHealth, emphasized the significance of this venture, stating, “We believe generative AI holds incredible potential to advance on the promise of technology to deliver meaningful transformation and efficiency for our caregivers and our patients. Its continued evolution requires input from industry professionals who can ensure safety and identify priority applications.” OhioHealth, a healthcare juggernaut encompassing 15 hospitals across 50 counties with a network of over 5000 dedicated physicians, sees a perfect synergy with Hippocratic AI’s focus on non-diagnostic solutions. Together, they are poised to ensure the technology’s safe and ethical development, ultimately leading to better and more equitable healthcare outcomes.
Hippocratic AI is at the forefront of creating the industry’s first safety-centric Large Language Model (LLM) tailored explicitly for healthcare. The initial focus of this endeavor lies in patient-facing, non-diagnostic applications. To achieve this milestone, Hippocratic AI has undertaken a multifaceted approach, which includes surpassing GPT-4 on more than 100 healthcare certifications, intensive training in healthcare-specific vocabulary, reinforcement learning with human feedback (RLHF) through healthcare professionals, and close collaboration with industry experts to guarantee the model’s utmost safety.
Michael Millie, MD, CMO at HarmonyCares, commented, “I’m excited about exploring our options for patient care with Hippocratic AI. Advancing technology in healthcare is key to improving our performance and delivering expert care to the patients we serve.” The vision of harnessing medical technology to enhance patient care and engagement is at the core of their collective mission.
Michael Gleeson, Co-founder and CTO at Guidehealth, added, “We see tremendous opportunity to support the needs of patients in value-based care contracts.” With Hippocratic AI’s capability to provide frequent wellness and clinical updates directly from patients, Guidehealth aims to expand its reach to individuals with rising health risks, thereby improving patient outcomes and enhancing the performance of value-based contracts.
Alicia Jackson, CEO and Founder of Evernow, stressed the importance of Hippocratic AI in the context of women’s health. She said, “In the U.S. — where there is only one licensed menopause practitioner per 33,000 women — we believe technologies like Hippocratic AI have the potential to help every woman access world-class care.” Evernow is proud to be the exclusive Early Access Partner in women’s health, and they are eager to leverage Hippocratic AI to elevate the depth and quality of care they provide to their members.
Early Access Partners are set to play a pivotal role in shaping Hippocratic AI’s product-market fit and design priorities, offering valuable clinical insights into the final commercial product suite. They will actively engage in:
- Collaborating on the design of ideal workflows to address critical health system challenges, staffing shortages, and opportunities for enhancing patient care.
- Contributing both clinical and non-clinical resources to support the development of initial use cases.
- Advocating for the safe development, implementation, and governance of AI in healthcare through education and awareness.
- Piloting early use cases in sandbox environments to assess readiness for deployment.
Meenesh Bhimani MD, Co-Founder & Chief Medical Officer of Hippocratic AI, summed up their mission, stating, “Hippocratic AI is on a mission to increase access and equity, and provide an unprecedented level of care, but we can’t do it alone. That’s why collaboration is so fundamental to everything we do.” This collaborative effort with industry leaders is poised to shape the development of a technology with the potential to address critical staffing shortages and revolutionize healthcare delivery.
Conclusion:
Hippocratic AI’s Early Access Partnership Program marks a significant step towards leveraging AI to transform the healthcare industry. By collaborating with key healthcare players, the program aims to develop safe and effective solutions that can improve patient care, address industry challenges, and drive innovation. This initiative reflects a growing trend in healthcare towards embracing AI and technology as essential tools for enhancing healthcare outcomes.
